Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
==================================================================================================================================================

* Matthew G Cyr
* Maissa Mhibik
* Junpeng Qi
* Haiyong Peng
* Jing Chang
* Erika M Gaglione
* David Eik
* John Herrick
* Thomas Venables
* Scott J Novick
* Valentine V Courouble
* Patrick R Griffin
* Adrian Wiestner
* Christoph Rader